Estadístiques de High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer
Visites totals
| views | |
|---|---|
| High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer | 45 |
Visites totals per mes
| views | |
|---|---|
| July 2024 | 0 |
| August 2024 | 5 |
| September 2024 | 10 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 1 |
| January 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| Palafox_nc_high.pdf(legacy) | 25 |
| Palafox_nc_high.pdf | 5 |
Vistes principals per país
| views | |
|---|---|
| United States | 35 |
| Australia | 4 |
| Spain | 2 |
| Argentina | 1 |
| China | 1 |
| Greece | 1 |
| Malaysia | 1 |
Visites principals per ciutat
| views | |
|---|---|
| San Ramon | 5 |
| Mountain View | 4 |
| Boardman | 3 |
| Fairfield | 3 |
| Menlo Park | 3 |
| Ashburn | 2 |
| Barcelona | 2 |
| Cambridge | 2 |
| Redmond | 2 |
| Sacramento | 2 |
| San Diego | 2 |
| San Mateo | 2 |
| Ann Arbor | 1 |
| Athens | 1 |
| Dearborn | 1 |
| Inverloch | 1 |
| Petaling Jaya | 1 |
| Pinjarra | 1 |
| Shenzhen | 1 |
| Suipacha | 1 |